학술논문
Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])
Document Type
Article
Author
Source
In: Stroke . (Stroke, 1 January 2017, 48(1):145-151)
Subject
Language
English
ISSN
15244628
00392499
00392499